Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
BMC Endocr Disord. 2010 May 17;10:9. doi: 10.1186/1472-6823-10-9.
Transcription factor 7-like 2 (TCF7L2) has emerged as a consistently replicated susceptibility gene for type 2 diabetes, however, whether the TCF7L2 gene also has similar effects on the retinal microvasculature is less clear. We therefore aimed to investigate the association between the transcription factor 7-like 2 (TCF7L2) rs7903146 polymorphism and retinal microvascular phenotypes in the Atherosclerosis Risk in Communities (ARIC) Study (1993-1995).
This was a population-based, cross-sectional study of 10,320 middle-aged African American (n = 2,199) and Caucasian (n = 8,121) men and women selected from four United States communities to examine the association between TCF7L2 rs7903146 polymorphism and retinal microvascular signs (retinopathy, focal arteriolar narrowing, arteriovenous nicking, arteriolar and venular calibers). Photographs on one randomly selected eye were graded for presence of retinal microvascular signs and used to measure retinal vessel calibres.
After adjusting for age, sex, study center, mean arterial blood pressure, total serum cholesterol, triglycerides, and other covariates, few associations of TCF7L2 rs7903146 and retinal microvascular signs were noted. TCF7L2 rs7903146 T risk allele was significantly associated with focal arteriolar narrowing in Caucasians with hypertension [odds ratio (OR)CT vs. CC (95% CI) = 1.25 (1.09-1.44); ORTT vs. CC = 1.56 (1.18-2.06); P = 0.002] and in Caucasians without diabetes [OR CT vs. CC = 1.18 (1.06-1.32); OR TT vs. CC = 1.40 (1.12, 1.75); P = 0.003]. No significant association of the TCF7L2 rs7903146 polymorphism and retinal vascular signs was noted among African American individuals.
TCF7L2 rs7903146 is not consistently associated with retinal microvascular signs. However, we report an association between the TCF7L2 rs7903146 polymorphism and focal arteriolar narrowing in Caucasians with hypertension or without diabetes. Further research in other large, population-based studies is needed to replicate these findings.
转录因子 7 样 2(TCF7L2)已成为 2 型糖尿病一致复制的易感基因,然而,TCF7L2 基因是否对视网膜微血管也有类似的影响尚不清楚。因此,我们旨在研究转录因子 7 样 2(TCF7L2)rs7903146 多态性与动脉粥样硬化风险社区(ARIC)研究(1993-1995 年)中视网膜微血管表型之间的关系。
这是一项基于人群的横断面研究,纳入了来自美国四个社区的 10320 名中年非裔美国人(n=2199)和白种人(n=8121)男性和女性,以研究 TCF7L2 rs7903146 多态性与视网膜微血管征象(视网膜病变、局灶性小动脉狭窄、动静脉吻合、小动脉和小静脉直径)之间的关系。随机选择一只眼的照片进行视网膜微血管征象分级,并用于测量视网膜血管直径。
在校正年龄、性别、研究中心、平均动脉压、总血清胆固醇、甘油三酯和其他混杂因素后,TCF7L2 rs7903146 与视网膜微血管征象的相关性很小。TCF7L2 rs7903146 T 风险等位基因与高血压白种人中的局灶性小动脉狭窄显著相关[比值比(OR)CT 与 CC(95%CI)=1.25(1.09-1.44);ORTT 与 CC = 1.56(1.18-2.06);P=0.002]和白种人中无糖尿病[OR CT 与 CC = 1.18(1.06-1.32);OR TT 与 CC = 1.40(1.12,1.75);P=0.003]。在非裔美国人中,TCF7L2 rs7903146 多态性与视网膜血管征象之间没有显著的相关性。
TCF7L2 rs7903146 与视网膜微血管征象不一致。然而,我们报告了 TCF7L2 rs7903146 多态性与高血压或无糖尿病的白种人局灶性小动脉狭窄之间的关联。需要在其他大型人群研究中进一步研究以复制这些发现。